Antibodies to a polypeptide encoded by a nucleic acid underexpressed in melanoma
View Patent ↗The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
1. A method for the diagnosis of melanoma comprising:
(a) identifying a patient suspected of having neoplastic disease; and
(b) detecting expression of a polypeptide having the amino acid sequence of SEQ ID NO: 24 in a test sample from said patient,
wherein lower expression of said polypeptide in said test sample as compared to a normal control sample indicates the presence of melanoma.
2. The method of claim 1 , wherein the test sample and control sample are tissue from skin.
3. The method of claim 1 , wherein said test sample is selected from the group consisting of a cultured cell line, primary tumor, tissue, cells, and blood.
4. The method of claim 1 , wherein said detecting of expression of said polypeptide in said test sample is detected using an antibody that specifically binds to the polypeptide of SEQ ID NO:24.
5. The method of claim 4 , wherein said antibody is detectably labeled.
6. The method of claim 4 , wherein said antibody is a monoclonal antibody.
7. The method of claim 4 , wherein said antibody is a humanized antibody.
8. The method of claim 4 , wherein said antibody is an antibody fragment.
9. The method of claim 8 , wherein the antibody fragment is selected from the group consisting of Fv, Fab, Fab′, and F(ab′)2 fragments.